Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Illumina's preliminary Q4 revenue and adjusted EPS exceed expectations

Illumina's preliminary Q4 revenue and adjusted EPS exceed expectations

格隆汇格隆汇2026/01/14 02:07
Show original
By:格隆汇
Gelonghui January 14th|Gene sequencing solutions company Illumina announced its preliminary results for the fourth quarter, with revenue reaching $1.155 billion, up 5% year-on-year and exceeding analysts' expectations of $1.1 billion. Adjusted earnings per share were between $1.27 and $1.3, also above the expected $1.21. The company has partnered with pharmaceutical companies such as AstraZeneca, Merck, and Eli Lilly to launch the world's largest whole-genome genetic perturbation dataset to accelerate AI-driven drug discovery.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
© 2025 Bitget